Samir Arora

Alstom (United States) — United States

Medicine · Health Sciences

14h-index2.3kcitations33works0.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Obstructive Pulmonary Disease (COPD) Research(11), Inhalation and Respiratory Drug Delivery(11), Asthma and respiratory diseases(6), Respiratory Support and Mechanisms(5), Diabetes Management and Research(4)

Publications32 total

A Phase 1b, Double-Blind, Placebo-Controlled Study of DISC-0974, an Anti-hemojuvelin Antibody, in Patients with Nondialysis-Dependent CKD and Anemia
Journal of the American Society of Nephrology·2024
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study
Diabetes Obesity and Metabolism·2024· 3 cited
Author response for "Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study"
2024
Author response for "Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study"
2024
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
JAMA·2023· 564 citedOpen Access
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds
Clinical Infectious Diseases·2023· 18 citedOpen Access
A Phase 1b Double-Blind, Placebo-Controlled Study of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Non-Dialysis Dependent Chronic Kidney Disease and Anemia
Blood·2023· 2 cited
Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial
˜The œLancet. Gastroenterology & hepatology·2023· 54 cited
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents
JAMA Network Open·2023· 48 citedOpen Access
579: SAFETY, TOLERABILITY AND PHARMACODYNAMIC ASSESSMENT OF KAN-101, A NOVEL LIVER-TARGETED THERAPY TO INDUCE IMMUNOLOGICAL TOLERANCE TO GLIADIN IN CELIAC DISEASE
Gastroenterology·2022· 4 cited
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
The Lancet·2021· 588 cited
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine
JAMA Network Open·2021· 59 citedOpen Access
Do we need more patient‐friendly treatment options for overactive bladder (OAB)?
Neurourology and Urodynamics·2021· 5 citedOpen Access
High HBsAb titers consistent across 3 lots of the trivalent HepB vaccine, Sci-B-Vac: Results from the second pivotal phase 3 double-blind, randomized controlled trial designed to assess the lot-to-lot consistency of Sci-B-Vac in adults (CONSTANT)
Journal of Hepatology·2020· 1 citedOpen Access
PD21-10 EVOKED EMG AS A METHOD FOR CONFIRMING TIBIAL NERVE RECRUITMENT IN SUBJECTS WITH OAB
The Journal of Urology·2020Open Access
<p>Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies</p>
International Journal of COPD·2020· 3 citedOpen Access
Benefits of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) in Reducing Exacerbation Risk in Patients with Moderate-to-Very Severe COPD: A Pooled Analysis of the PINNACLE Studies
2019· 1 cited
Benefits of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) in Symptomatic Patients with COPD: A Post-Hoc Analysis from a Phase III, Randomized, Placebo-Controlled Study (PINNACLE-4)
2019· 1 cited
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Improves Lung Function in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies
2019· 3 cited
Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration
The Journal of Sexual Medicine·2018· 5 cited
page 1 of 2Next →

Frequent Co-authors

Colin Reisner(11), Harold Bays(6), Gregory Feldman(6), Ubaldo J. Martin(6), Michael Lillestol(5), Gregory Gottschlich(5), Shahid Siddiqui(5), Andrea Maes(5), Chad Orevillo(5), Joseph Soufer(4), Douglas Denham(4), Barbara Rizzardi(4), Brian J. Lipworth(4), Danny Sugimoto(4), Martin Jenkins(4), Alan Wynne(3), Clancy Cone(3), Gary T. Ferguson(3), Edward Kerwin(3), Klaus F. Rabe(3)